TGFB1 and breast cancer: However, we suggest that TGF-β and Wnt signaling pathways whose activation is complex and known to promote EMT in different carcinomas including ovarian and breast cancer (57, 58), and highlighted in this study as downregulated in the transcriptomic analysis, might play a role in this regard.